Fact-checked by Grok 2 weeks ago

Peritonsillar abscess

A peritonsillar abscess (PTA), also known as quinsy, is a localized collection of pus that forms in the peritonsillar space between the tonsillar capsule and the pharyngeal constrictor muscle as a complication of acute tonsillitis. It represents the most common deep infection of the head and neck region. This condition primarily arises from bacterial infection, most often involving group A beta-hemolytic Streptococcus (Streptococcus pyogenes), though it is frequently polymicrobial, incorporating oral flora such as anaerobes like Fusobacterium and Prevotella species. Risk factors include prior episodes of tonsillitis, smoking, and possibly seasonal variations, with higher incidence reported in spring and winter in some regions. In the United States, the annual incidence is approximately 30 cases per 100,000 individuals, translating to about 45,000 new cases yearly, predominantly affecting adolescents and young adults aged 15 to 30 years, with males showing a slight predominance in certain studies. Clinically, patients present with severe, unilateral throat pain, fever, (painful swallowing), (limited mouth opening), and a characteristic muffled "hot potato" voice due to peritonsillar swelling. Additional features may include , ipsilateral otalgia, , and uvular deviation toward the unaffected side on examination, reflecting the asymmetric inflammation. If untreated, complications such as airway obstruction, , or spread to deeper neck spaces can occur, though these are rare with prompt intervention. Diagnosis is chiefly clinical, based on history and physical findings, with imaging such as reserved for atypical presentations or suspected complications to confirm the abscess and rule out alternative pathologies like parapharyngeal abscess. Treatment typically involves empiric intravenous antibiotics targeting streptococci and anaerobes (e.g., penicillin plus ), combined with drainage via needle aspiration, , or, in recurrent cases, immediate . Supportive care includes analgesia, hydration, and monitoring for airway compromise, with most patients recovering fully within days to weeks.

Definition and pathophysiology

Definition

A peritonsillar abscess () is defined as a localized collection of within the peritonsillar space, situated between the tonsillar capsule and the superior constrictor muscle of the . Also known historically as quinsy, this condition represents a suppurative complication typically arising from untreated or inadequately managed acute . The peritonsillar space is a potential anatomical compartment bounded medially by the , laterally by the , and posteriorly by the . Abscess formation most commonly occurs at the superior pole of the tonsil, accounting for 41% to 70% of cases, with less frequent involvement at the inferior pole or mid-tonsillar region. PTA must be differentiated from peritonsillar , which involves inflammatory in the same space but lacks a pus collection and is considered a precursor stage.

A peritonsillar abscess typically arises as a complication of acute bacterial , where the initial within the palatine tonsils leads to suppuration and pus accumulation in the peritonsillar space—a between the tonsillar capsule and the superior constrictor muscle of the . The process begins with bacterial invasion of the tonsillar or crypts, progressing to localized when the pathogens breach the tonsillar barrier and enter the adjacent peritonsillar . Several mechanisms explain the spread of to the peritonsillar space. Direct extension from the is a primary pathway, allowing to invade the laterally and superiorly. Additionally, involvement of the Weber glands—minor salivary glands located in the supratonsillar fossa—may serve as a nidus, where ductal obstruction leads to bacterial overgrowth and abscess formation. The inflammatory response in peritonsillar abscess involves intense local , hyperemia, and tissue necrosis driven by the host immune reaction to bacterial toxins and enzymes. Mixed aerobic and flora, often originating from the oral , synergistically promote abscess maturation by producing proteolytic enzymes that liquefy tissue and facilitate formation. A fibrous capsule eventually forms around the necrotic debris and , walling off the infection but potentially delaying resolution due to reduced vascularity and poor antibiotic penetration in the avascular core. The condition evolves through stages, starting as peritonsillar —a diffuse, non-localized phlegmonous characterized by widespread without discrete pus collection. If untreated, this progresses to a mature , marked by a fluctuant, encapsulated pus pocket, often influenced by factors such as impaired host immunity or persistent bacterial that hinders clearance.

Clinical presentation

Signs and symptoms

Patients with peritonsillar abscess typically present with severe unilateral , often described as the most intense in the affected area. This is accompanied by , making swallowing extremely painful, and , which contributes to reduced oral intake. Fever is a common systemic symptom, frequently exceeding 38.5°C, along with , , and headaches. Voice changes are characteristic, including a muffled or "hot potato" voice due to peritonsillar swelling affecting . On , is a hallmark sign, resulting from irritation of the internal pterygoid muscle and limiting mouth opening to less than 2 cm in many cases. is evident, with enlargement and bulging of the affected and toward the contralateral side, often accompanied by uvular deviation away from the abscess. Unilateral may be visible on the , and the appears erythematous and swollen. , particularly tender anterior cervical nodes, is frequently observed ipsilateral to the abscess. Associated features include due to painful , halitosis from , and referred otalgia to the ipsilateral . The condition often progresses from initial symptoms of acute that fail to resolve, with worsening unilateral symptoms over 2-5 days. Bilateral peritonsillar abscess is rare, occurring in less than 5% of cases, and presents with symmetric swelling, bilateral , and muffled voice without uvular deviation.

Complications

Untreated or inadequately managed peritonsillar abscess can lead to serious local complications, primarily due to progressive swelling and potential rupture of the abscess. Airway obstruction is a rare but life-threatening outcome, resulting from extensive that compromises breathing, particularly when severe limits mouth opening and exacerbates the risk. Rupture of the abscess into adjacent deep neck spaces may cause rapid spread of , potentially leading to , a bilateral of the that causes floor-of-mouth elevation and further airway compromise. Systemic complications arise from dissemination of the beyond the peritonsillar region. Bacteremia and occur in a significant proportion of cases, with approximately half of patients meeting diagnostic criteria, often linked to factors like or delayed antibiotic therapy. Extension into the can produce and further propagate , while deeper spread may result in descending mediastinitis, a severe necrotizing of the reported in multiple cases. Recurrent peritonsillar abscesses represent a common , with an overall recurrence rate of approximately 10 to 15 percent in the absence of , potentially evolving into chronic tonsillitis with repeated episodes of inflammation. Rare complications include , a variant of involving septic , and intracranial extension such as , both of which carry high morbidity. Immunocompromised patients face increased risk of severe morbidity from these infections due to impaired host defenses, often requiring more aggressive intervention.

Etiology and risk factors

Causes

Peritonsillar abscess (PTA) is primarily caused by bacterial infections originating from the oral flora, often progressing from an initial episode of acute tonsillitis. The condition typically arises when bacteria invade the peritonsillar space, leading to localized pus accumulation. The predominant pathogen is Group A Streptococcus (Streptococcus pyogenes), which is identified in 20-30% of cases and is considered the most common aerobic isolate. Other frequent streptococcal species include Group C and G streptococci, as well as viridans group streptococci such as Streptococcus anginosus (formerly milleri group). Anaerobic bacteria play a significant role, with Fusobacterium necrophorum (prevalent in adolescents and young adults) and Prevotella species commonly isolated. Most PTAs exhibit a polymicrobial nature, involving mixed aerobic and anaerobic infections derived from the normal tonsillar and oral microbiota. This combination facilitates abscess formation through synergistic bacterial interactions, where aerobes like streptococci may create conditions favorable for anaerobe proliferation in the tonsillar crypts. PTA most commonly develops as a suppurative complication of bacterial pharyngitis or tonsillitis, allowing infection to spread from the tonsillar parenchyma to the peritonsillar space. Less common causes include superinfections following viral upper respiratory infections, such as those associated with infectious mononucleosis, and rare non-infectious mimics like foreign bodies in the tonsillar area or neoplastic processes presenting similarly. However, these are exceptional, with bacterial etiology confirmed in the vast majority of instances.

Risk factors

Peritonsillar abscess (PTA) predominantly affects adolescents and young adults, with the highest incidence occurring between the ages of 15 and 30 years. This age group experiences peak rates, potentially due to increased exposure to infectious agents in social settings and anatomical factors related to tonsillar development. The condition is slightly more common in males, particularly after adolescence, although the overall male-to-female ratio approximates 1:1, with females tending to present at younger ages. A history of recurrent (such as five or more prior episodes) significantly predisposes individuals to PTA, as repeated episodes of tonsillar infection can lead to local tissue damage and bacterial . Additionally, a prior PTA episode markedly increases the likelihood of recurrence, with rates reported between 10% and 15%. Behavioral and environmental factors play a key role in susceptibility. is a well-established , as it impairs mucosal defenses and promotes bacterial in the oropharynx, with studies indicating a dose-dependent association. Poor , including significant , further heightens risk by facilitating polymicrobial infections. Seasonal viral infections, such as those caused by Epstein-Barr virus (EBV) or , can act as triggers by inducing local and paving the way for secondary bacterial invasion. Comorbidities and anatomical variations also contribute to PTA development. Immunosuppressive conditions, including and diabetes mellitus, compromise host defenses, leading to higher susceptibility and more severe presentations; for instance, independently elevates PTA . Anatomical abnormalities, such as enlarged tonsils or deep , may obstruct drainage and promote abscess formation. Furthermore, individuals in low socioeconomic settings are at greater due to barriers to timely medical care, resulting in progression from uncomplicated to abscess.

Diagnosis

Clinical assessment

The clinical assessment of peritonsillar abscess begins with a detailed history taking to identify key features suggestive of the condition. Patients typically report a severe lasting several days, often preceded by , accompanied by fever, , and the recent onset of that limits mouth opening. Systemic symptoms such as and may also be elicited, helping to gauge severity and duration. Physical examination focuses on intraoral inspection and palpation to detect characteristic abnormalities. Asymmetry in the oropharynx is common, with unilateral tonsillar enlargement, peritonsillar edema, and medial displacement of the soft palate or uvula toward the contralateral side; bimanual palpation along the superior tonsillar pole may reveal fluctuance indicating pus collection. Trismus is assessed by measuring interincisor distance, where opening less than 2 cm is highly suggestive due to irritation of the internal pterygoid muscle. A muffled "hot potato" voice and drooling may be noted during the exam. The presumptive diagnosis relies on the constellation of these clinical signs, which collectively offer high diagnostic accuracy. For instance, the presence of deviation, hot potato voice, and pharyngeal demonstrates a sensitivity of approximately 90% for peritonsillar abscess in recent prospective studies. combined with peritonsillar swelling further supports suspicion. Differential diagnosis during assessment includes distinguishing peritonsillar abscess from or , which may present with similar but lack unilateral tonsillar asymmetry and show more diffuse airway involvement on exam. Careful evaluation of voice quality and neck mobility aids in ruling out these alternatives.

Diagnostic tests

Diagnosis of peritonsillar abscess (PTA) often involves ancillary investigations to confirm the presence of a fluid collection and identify potential complications, particularly when clinical assessment is equivocal. Imaging modalities play a key role in visualization, with intraoral serving as a first-line, non-invasive option due to its portability and lack of . demonstrates high , approximately 89-95%, for detecting fluid collections indicative of PTA, allowing for differentiation from peritonsillar by identifying hypoechoic areas adjacent to the . Its specificity ranges from 78-100%, making it effective for ruling out abscesses in emergency settings and guiding needle to avoid vascular structures like the . Computed tomography () with contrast enhancement is reserved for cases with suspected complications, such as deep neck extension or airway involvement, revealing a rim-enhancing fluid collection adjacent to the enlarged with 100% and 75% specificity. Laboratory tests provide supportive evidence of but are not diagnostic on their own. A (CBC) typically shows with a left shift, reflecting in response to bacterial . Elevated (CRP) and (ESR) levels indicate systemic inflammation, often correlating with disease severity and hospitalization duration. Throat swabs for or rapid antigen detection testing for group A have low yield in confirming PTA etiology, as surface cultures do not reliably sample the abscess cavity, with positivity rates as low as 8% in impending cases. Needle aspiration of the suspected abscess serves as the gold standard for microbiologic confirmation, providing pus for Gram stain, culture, and sensitivity testing to guide antibiotic therapy. This invasive procedure not only confirms the diagnosis by yielding purulent material but also offers therapeutic drainage, though it carries risks such as vascular injury if not ultrasound-guided. Emerging research in 2025 has explored serological markers to aid differentiation between PTA and peritonsillar cellulitis without invasive procedures. Elevated serum levels of high-mobility group box 1 (HMGB1) and reduced kallistatin show promise as biomarkers, with receiver operating characteristic analysis indicating potential diagnostic utility in research settings, though they are not yet part of routine clinical practice.

Treatment

Medical management

Medical management of peritonsillar abscess primarily involves empiric antibiotic therapy targeted at the polymicrobial , including Streptococcus and oral anaerobes, alongside supportive measures to alleviate symptoms and maintain hydration. Initial treatment typically consists of intravenous penicillin G (2-4 million units every 4-6 hours) or clindamycin (600-900 mg every 8 hours) for hospitalized patients, as these agents provide broad coverage against the predominant pathogens. This regimen demonstrates high efficacy, with penicillin-based therapy achieving resolution rates of 95-99% when combined with in most cases, though antibiotics alone can be effective in select scenarios. duration is generally 10-14 days, transitioning to oral amoxicillin-clavulanate (875 mg twice daily) once the patient tolerates oral intake and clinical improvement occurs. For patients with , clindamycin remains the preferred alternative due to its anaerobic coverage. Supportive care focuses on symptom relief and prevention of complications from and . Analgesics such as ibuprofen (400-600 mg every 6-8 hours) or acetaminophen (500-1000 mg every 4-6 hours) are used to control pain and fever, often supplemented with nonsteroidal anti-inflammatory drugs for their anti-inflammatory effects. Corticosteroids, such as dexamethasone (8-10 mg IV) or (2-3 mg/kg IV), may be administered to reduce swelling and improve symptoms. Hydration is maintained through intravenous fluids if oral intake is impaired, and antiemetics like (4-8 mg as needed) may be administered to manage associated with severe swallowing pain. These measures help stabilize patients while antibiotics take effect, typically within 24-48 hours. In cases of small abscesses, particularly those less than 2 cm in diameter with minimal symptoms, with antibiotics alone is a viable option, avoiding immediate . Recent pediatric studies support this approach, reporting success rates of approximately 94% in avoiding surgical intervention within two weeks, with primary failure rates around 6% and no reported complications in selected children under 13 years. This strategy is most appropriate for younger patients or those without airway compromise, emphasizing close follow-up to monitor resolution. Monitoring is essential, especially in severe cases warranting hospitalization for , fluid support, and airway observation to detect potential obstruction from swelling. Regimens should be adjusted for local resistance patterns; if (MRSA) is suspected based on risk factors or culture results, (15-20 mg/kg every 8-12 hours) is added for coverage. may serve as an adjunct in non-responders, but medical optimization remains the cornerstone.

Surgical interventions

Surgical interventions for peritonsillar abscess () primarily focus on draining the collection to alleviate symptoms and prevent complications, with techniques ranging from minimally invasive procedures to more definitive surgical options. serves as the first-line drainage method, often feasible in an outpatient setting under . This procedure involves using an 18- to 20-gauge needle to puncture the most fluctuant area of the , typically at the superior pole of the , allowing for both via pus confirmation and therapeutic evacuation of contents. Studies indicate recurrence rates of 10-15% following needle aspiration, though it remains cost-effective and less invasive than alternatives. Incision and drainage (I&D) offers a more thorough approach for larger or multiloculated abscesses, performed under by making a small incision over the fluctuant area followed by blunt and evacuation. This method is considered more definitive than needle aspiration, with lower reported recurrence rates in comparative studies, and can be completed in an office or emergency setting. I&D may require repeat procedures in up to 10% of cases but provides superior yield and visualization of the cavity. For patients with recurrent PTA or failure of initial drainage, advanced surgical options include quinsy tonsillectomy, which entails immediate bilateral during the acute infection phase. This procedure is particularly indicated for recurrent cases and has demonstrated high efficacy with low complication rates in experienced hands, addressing the underlying tonsillar pathology directly. Alternatively, interval tonsillectomy is performed electively 6-8 weeks after abscess resolution, allowing to subside and reducing perioperative risks while preventing future episodes in those with a history of recurrent . In pediatric patients, where cooperation may be challenging, conscious sedation is increasingly utilized during procedures to enhance tolerability. Recent 2024 prospective studies report that conscious sedation facilitates effective with greater pus volume evacuated (mean 4.9 mL versus 3.2 mL with alone) and excellent safety profiles, including no major airway events. For smaller abscesses in children, less invasive alternatives such as ultrasound-guided aspiration under sedation may be preferred to minimize trauma. Post-procedure care involves administering culture-directed antibiotics based on aspirate analysis to target pathogens like Streptococcus pyogenes, alongside close follow-up to monitor for resolution of trismus, dysphagia, and fever. Potential complications include bleeding, occurring in approximately 1-2% of drainage cases, though rates rise to 11-13% following tonsillectomy; most are managed conservatively or with hemostasis.

Epidemiology and prognosis

Epidemiology

Peritonsillar abscess (PTA) has an annual incidence of approximately 30 cases per 100,000 persons in developed countries, primarily affecting individuals aged 5 to 49 years. In the United States, this translates to an estimated 45,000 new cases each year. The condition is most prevalent among adolescents and young adults, with rates reaching up to 40 cases per 100,000 person-years in those aged 15 to 19, compared to 30 to 40 cases per 100,000 in adults overall. Males show a slight predominance. In pediatric populations, incidence remains stable at 20 to 30 cases per 100,000 annually, though it is rarer in children under 5 years. Historical trends indicate a relatively stable incidence in developed countries around 30 per 100,000. However, post-COVID-19 data from and reveal shifts, including a temporary decrease during nonpharmaceutical interventions (14.9 cases per ) followed by a rebound to 26.9 cases per after restrictions lifted, potentially due to delayed care and accumulated infections. Incidence exhibits seasonal peaks in winter and spring, correlating with higher rates of respiratory infections. Geographic variations show higher PTA rates in rural and low-resource settings, where access to timely for is limited. Studies indicate that over 50% of non-streptococcal pathogens in PTA cultures show penicillin resistance, complicating .

Prognosis

With appropriate , peritonsillar abscess (PTA) typically resolves rapidly, with 90-95% of cases showing significant symptom improvement within 24-48 hours. Hospitalization duration typically ranges from 2 to 4 days, though it can extend to 5-7 days in complicated cases. The risk of recurrence following a single episode is estimated at 5-15%, but rises to 20-30% in patients with prior recurrent or multiple abscess episodes. Recent 2025 data indicate that conservative in pediatric cases achieves success in approximately 87% of patients, thereby reducing the immediate need for surgical . Prognosis is influenced by several factors, including timely ; delays can increase the of complications such as airway obstruction. Outcomes are generally more favorable in immunocompetent individuals without underlying comorbidities. Long-term sequelae are rare, with reducing the of future PTA by 80-90% in high-risk patients. Overall mortality is less than 0.1% with modern care, though it can rise significantly if treatment is delayed leading to severe complications.

History and etymology

Historical background

The peritonsillar abscess, historically known as quinsy, was first recognized in ancient medical texts as a severe suppurative of the . , around 400 BCE, described quinsy as a painful swelling of the tonsils accompanied by fever and difficulty , recommending as a therapeutic approach when suppuration occurred. In the Roman era, , in the first century CE, further detailed the condition in his work De Medicina, advocating for surgical incision to relieve the abscess and prevent complications such as airway obstruction, marking an early milestone in its surgical management. By the , anatomical understanding advanced, with Italian physician Morgagni contributing to the pathological description of deep neck infections, including those akin to peritonsillar abscesses, through his systematic postmortem studies in De Sedibus et Causis Morborum per Anatomem Indagatis. In the , management relied primarily on , with less invasive needle techniques developed in the mid-20th century and gaining widespread adoption in the 1980s for outpatient treatment. The 20th century brought transformative changes with the advent of antibiotics in the , particularly penicillin, which dramatically reduced the incidence and mortality of streptococcal infections, including peritonsillar abscesses, by targeting group A , the primary pathogen. Pre-antibiotic era mortality rates for complicated peritonsillar and deep neck infections could reach 25%, dropping to less than 1% post-World War II due to penicillin and improved care, leading to a significant decline in severe suppurative complications. From the onward, a shift toward emerged, emphasizing outpatient needle aspiration combined with oral antibiotics over immediate surgical intervention, supported by studies demonstrating high success rates and reduced hospitalization needs. In the mid-20th century, initial studies explored outpatient approaches; by the , Herzon's work demonstrated high success with needle aspiration and antibiotics, further promoting this shift. In the , imaging-guided techniques have gained prominence, with recent studies from 2024 and 2025 highlighting the use of for and, in select cases, guided to aid precise localization and while minimizing risks like vascular injury in emergency settings. These advancements reflect ongoing refinements in and procedural safety, building on the foundational surgical principles established centuries earlier.

Etymology

The term "peritonsillar abscess" combines the Greek prefix peri-, meaning "around" or "about," with tonsillar, pertaining to the tonsils, and abscess, denoting a localized collection of pus. The word tonsil derives from Latin tonsillae (plural), a diminutive form possibly related to tōlēs, referring to a swollen gland or goiter, evoking the almond-like shape of these lymphoid structures in the throat. Abscess originates from Latin abscessus, the past participle of abscēdere ("to go away" or "separate"), which in ancient medical theory described the "departure" of harmful humors as pus. Historically, the condition has been known by the synonym quinsy, a term prevalent in English medical and lay usage until the early 20th century. Quinsy stems from quinesye, borrowed from quinencie and quinancia, tracing back to kynanchē—a of kyn- (from kyōn, "") and anchein ("to strangle" or "choke")—capturing the sensation of constriction akin to a dog's . The precise nomenclature "peritonsillar abscess" gained standardization in 19th-century medical texts, with the adjective peritonsillar entering English usage in the 1870s to accurately denote the suppurative collection in the space surrounding the tonsillar capsule. Earlier or alternative designations, such as "paratonsillar abscess," appeared occasionally but were deemed anatomically imprecise, as the infection develops in the peritonsillar space rather than simply adjacent to the tonsil. In other languages, equivalent terms mirror this anatomical focus; for instance, the French "abcès périamygdalien" employs péri- (around) and amygdalien (from Latin , "," highlighting the tonsil's shape).

Notable cases

Historical cases

(c. 1100–1159), the only English pope, reportedly died from quinsy, a peritonsillar abscess, though some accounts suggest he choked on a fly in his wine. French Renaissance philosopher (1533–1592) died at age 59 from quinsy, which caused throat inflammation and deprived him of speech in his final days.

Modern cases

In 2017, English singer and actor of the band was hospitalized for quinsy as a complication of , requiring treatment and rest. personality was hospitalized for quinsy in 2016 and again in 2018 in , describing severe throat pain and swelling. Actress was rushed to hospital in 2019 for a diagnosed as quinsy, undergoing drainage due to intense pain.

References

  1. [1]
    Peritonsillar Abscess: Practice Essentials, Anatomy, Pathophysiology
    Sep 3, 2024 · A PTA is a localized accumulation of pus in the peritonsillar tissues that forms as a result of suppurative tonsillitis.Practice Essentials · Anatomy · Pathophysiology · Etiology
  2. [2]
    Peritonsillar Abscess - PubMed
    Apr 15, 2017 · Peritonsillar abscess is the most common deep infection of the head and neck, occurring primarily in young adults.
  3. [3]
  4. [4]
    Tonsillitis and Peritonsillar Abscess - PMC - PubMed Central - NIH
    Microbiology. Peritonsillar abscesses are generally polymicrobial, representing the normal flora of the oral cavity and tonsillar area.
  5. [5]
    Epidemiology and Clinical Features of Peritonsillar Abscess - NIH
    In spring, the PTA incidence was the highest (31.4%), and in summer and autumn, the incidence of PTA was found to be the lowest, 20.8% and 20% respectively ( ...
  6. [6]
    Epidemiology, clinical history and microbiology of peritonsillar abscess
    PTA is a disease usually affecting teenagers and young adults; its incidence is rare in infants and children. The majority of studies report male predominance; ...
  7. [7]
    Peritonsillar Abscess - StatPearls - NCBI Bookshelf - NIH
    Peritonsillar abscesses are localized collections of pus in peritonsillar space between the tonsillar capsule and superior constrictor muscle.
  8. [8]
    Peritonsillar Abscess (Quinsy): Symptoms, Treatments & Causes
    A peritonsillar abscess is a pus-filled pocket that forms near one of your tonsils. It causes pain and swelling. In severe cases, it can block your throat.
  9. [9]
    How To Drain a Peritonsillar Abscess - Merck Manuals
    A peritonsillar abscess is located between the tonsil capsule, the superior pharyngeal constrictor muscle, and the palatopharyngeus muscle. The abscess is not ...
  10. [10]
    Peritonsillar Abscess - AAFP
    Jan 15, 2008 · These abscesses generally form in the area of the soft palate, just above the superior pole of the tonsil, in the location of Weber's glands.
  11. [11]
    Peritonsillar swelling is not always quinsy - PMC - NIH
    Peritonsillar cellulitis is considered as a transition phase of the peritonsillar inflammatory process becoming an abscess or quinsy.
  12. [12]
    Peritonsillar Abscess - AAFP
    Apr 15, 2017 · Peritonsillar abscess is the most common deep infection of the head and neck, occurring primarily in young adults.
  13. [13]
    Peritonsillar Abscess Clinical Presentation - Medscape Reference
    Sep 3, 2024 · Patients with a peritonsillar abscess (PTA) typically present with a history of acute pharyngitis accompanied by tonsillitis and worsening unilateral ...<|control11|><|separator|>
  14. [14]
    Tonsillitis - StatPearls - NCBI Bookshelf - NIH
    Jul 7, 2025 · Uvular deviation (may indicate peritonsillar abscess). Posterior ... trismus, uvular deviation, and a muffled “hot potato” voice. Most ...
  15. [15]
    Bilateral peritonsillar abscess: A rare emergency - PubMed Central
    Peritonsillar abscess, or quinsy, is a rare complication of acute tonsillitis. It usually presents with odynophagia, trismus, and muffled voice.
  16. [16]
    Peritonsillar abscess subsequently complicated by Ludwig's angina
    The images of this article are clinical pictures of peritonsillar abscess subsequently complicated by Ludwig's angina of a 68‐year‐old man.
  17. [17]
    A Severe Case of Ludwig's Angina with a Complicated Clinical Course
    Apr 16, 2020 · The most common condition that causes Ludwig's angina is an odontogenic infection. Other potential causes include peritonsillar abscess, ...
  18. [18]
    Peritonsillar abscess is frequently accompanied by sepsis symptoms
    Half of the patients with PTA meet the diagnostic criteria for sepsis. The risk factors for the latter include current smoking and not receiving antibiotic ...Missing: bacteremia | Show results with:bacteremia
  19. [19]
    Complications of peritonsillar abscess
    Jul 30, 2020 · The vast majority of patients with peritonsillar abscess (PTA) recover uneventfully on abscess drainage and antibiotic therapy.
  20. [20]
    Peritonsillar abscess | Radiology Reference Article - Radiopaedia.org
    Apr 12, 2025 · Complications · retropharyngeal effusion · retropharyngeal abscess · septic thrombophlebitis of the internal jugular vein (Lemierre syndrome).Peritonsillar abscess · Peritonsillar abscess (quinsy) · Intratonsillar abscess
  21. [21]
    Case Report Brain Abscess From a Peritonsillar ... - ScienceDirect.com
    We describe a left frontal brain abscess accompanied by fever, headache, and weight loss for a 3-month period.
  22. [22]
    Treatment of Peritonsillar Abscess in Immunosuppressed Patients
    This case report will describe successful multi-modality treatment of two separate incidents of PTA developing in the context of immunosuppression.
  23. [23]
    Complications of peritonsillar abscess - PMC - NIH
    Jul 30, 2020 · The most frequently described complications were descending mediastinitis (n = 113), para- and retropharyngeal abscess (n = 96), necrotizing ...
  24. [24]
    Peritonsillar abscess: clinical aspects of microbiology, risk factors ...
    Group A streptococcus (GAS) is the only established pathogen in PTA. However, GAS is only recovered from approximately 20% of PTA patients. The pathogens in the ...
  25. [25]
    Unveiling the etiology of peritonsillar abscess using next generation ...
    Nov 8, 2023 · Peritonsillar abscess (PTA) is a collection of pus between the tonsil fibrous capsule and superior pharyngeal constrictor muscle. It is the most ...
  26. [26]
    Tonsillitis and Peritonsillar Abscess - Medscape Reference
    Aug 2, 2024 · Tonsillitis is inflammation of the palatine tonsils. The inflammation usually extends to the adenoid and the lingual tonsils; therefore, the term pharyngitis ...
  27. [27]
    Incidence of peritonsillar abscess and relationship to age and gender
    The highest incidence was found between 14 and 21 y of age, with 124/100,000/y. The male: female ratio was 1: 1. Affected females were younger than males (p= ...
  28. [28]
    Incidence and microbiology of peritonsillar abscess - PubMed
    Jan 29, 2014 · Girls predominated over boys until the age of 14 years. Subsequently, men were more frequently affected than women. Fusobacterium necrophorum ( ...Missing: demographics | Show results with:demographics
  29. [29]
    The Impact of Prior Tonsillitis and Treatment Modality on the ...
    There were 28,837 patients, with a 5.15% recurrence rate and 4.74 years of follow-up. The recurrence rates were significantly higher among subjects with more ...
  30. [30]
    Type 2 Diabetes Mellitus Increases Peritonsillar Abscess Susceptibility
    Our study aimed to investigate the risk, prognosis, and complications of peritonsillar abscess (PTA) in patients with T2DM.Missing: immunosuppression | Show results with:immunosuppression
  31. [31]
    Associations between Peritonsillar Abscess and Deep Neck ... - MDPI
    Apr 9, 2024 · In the socioeconomic environment, low socioeconomic status is supposed to increase susceptibility to DNI [28]. This high vulnerability to ...<|control11|><|separator|>
  32. [32]
    Peritonsillar Abscess and Cellulitis - Ear, Nose, and Throat Disorders
    The most serious consequences include airway obstruction, septic shock, rupture of the abscess into the airway resulting in aspiration pneumonia or asphyxia, ...Missing: bacteremia | Show results with:bacteremia
  33. [33]
    Diagnosis of Peritonsillar Abscess—A Prospective Study Comparing ...
    Jan 20, 2025 · Uvula deviation was defined as the shift of the uvula from the midline. Hot potato voice (or muffled voice) was defined by the lack of resonance ...
  34. [34]
    Test characteristics of ultrasound for the diagnosis of peritonsillar ...
    Ultrasound demonstrates high sensitivity for ruling out PTA, but it only has moderate specificity for ruling in the diagnosis.
  35. [35]
    The Use of Point of Care Ultrasound in Diagnosis of Peritonsillar ...
    POCUS has increasingly been used as an adjunct for diagnosis of PTA, with a sensitivity ranging from 89-95% and specificity of 78-100%.
  36. [36]
    Bedside Ultrasound for the Diagnosis of Peritonsillar Abscess - JETem
    Oct 11, 2017 · Although diagnosis of PTA using intraoral ultrasound has a sensitivity and specificity of between 89%-95% and 79%-100% respectively, it is ...
  37. [37]
    POCUS for Peritonsillar Abscess - Tampa Emergency Medicine
    Dec 6, 2022 · A step-by-step breakdown of how to efficiently use Ultrasound to find a possible PTA, including locating the all important carotid artery.
  38. [38]
    Peritonsillar Abscess Workup - Medscape Reference
    Sep 3, 2024 · Needle aspiration of the abscess site (see the image below) may be performed just before the drainage procedure is attempted. It allows ...
  39. [39]
    Throat Culture in Impending Peritonsillar Abscess - PubMed
    Throat cultures done immediately before the development of a peritonsillar abscess were positive for beta-hemolytic streptococci in only one of 12 cases.
  40. [40]
    The epidemiology of peritonsillar abscess disease in Northern Ireland
    Culture yield was greatest from needle aspirates; throat swabs and blood cultures were typically unhelpful. Beta haemolytic streptococci were the most ...
  41. [41]
    HMGB1 and Kallistatin: Novel Serological Markers for Differentiating ...
    Conclusions: Serum HMGB1 and kallistatin may be effective adjunctive biomarkers for differentiating PTA from PTC. Keywords: HMGB1 protein; ...
  42. [42]
    Peritonsillar Abscess Treatment & Management
    Sep 3, 2024 · Others have shown that immediate or delayed tonsillectomy may not be necessary because of the high rate of success and the low recurrence rate ...
  43. [43]
    Outcomes of conservative antibiotic therapy in pediatric peritonsillar ...
    Sep 18, 2025 · Our findings suggest that conservative management of pediatric PTA with antibiotics is a safe and effective approach in selected cases. While ...
  44. [44]
    Peritonsillar/Retropharyngeal Abscess
    ID consultation is recommended for head and neck infections occurring in immunocompromised patients, and for those with atypical features, chronic course, or ...Missing: complications | Show results with:complications
  45. [45]
    Needle aspiration versus incision and drainage for the treatment of ...
    Recurrence in the needle aspiration group ranged from 4.9% to 80.0%. In the incision and drainage group recurrence ranged from 0% to 20%. The studies that ...
  46. [46]
    A Randomized Trial for Outpatient Management of Peritonsillar ...
    These data indicate that outpatient permucosal needle drainage of peritonsillar abscess is an acceptable, inexpensive treatment comparing favorably with ...
  47. [47]
    The Surgical Treatment of Peritonsillar Abscess: A Retrospective ...
    Jun 10, 2021 · For PTA, principally three surgical options are described: needle aspiration (NA), incision and drainage (ID), and abscess tonsillectomy (ATE, ...
  48. [48]
    Immediate tonsillectomy for peritonsillar abscess - ScienceDirect.com
    In this paper, we review these 103 cases and conclude that immediate tonsillectomy is the most safe and effective treatment for PTA.
  49. [49]
    [PDF] Early Interval Tonsillectomy as Compared to Delayed Interval ...
    The surgical treatment involves needle aspiration, incision drainage and tonsillectomy.The procedure of tonsillectomy done in PTA patient on emergency basis ...
  50. [50]
    Conscious sedation for the management of peritonsillar abscess in ...
    Jul 14, 2024 · Conclusions: Conscious sedation facilitates PTA drainage with excellent safety and improved efficacy compared to local anesthesia in children.
  51. [51]
    The peritonsillar abscess and its management – is incision and ...
    Nov 28, 2023 · This study aims to examine the long-term management of peritonsillar abscess and compare needle aspiration, incision with drainage, and tonsillectomy.Abstract · Introduction · Results · DiscussionMissing: pathophysiology | Show results with:pathophysiology<|control11|><|separator|>
  52. [52]
    Peritonsillar Abscess - DynaMed
    Sep 13, 2024 · Untreated or inadequately treated infections are a risk factor for peritonsillar abscess, including oropharyngeal infections such as ...Missing: percentage | Show results with:percentage
  53. [53]
    At what age are peritonsillar abscesses most commonly diagnosed?
    Sep 30, 2025 · Adolescents and young adults: Highest incidence (40 cases per 100,000 person-years) 2. Adults aged 20-40: Most common demographic, with mean ...
  54. [54]
    Recognizing a Peritonsillar Abscess in Pediatric Patients | CE Article
    Peritonsillar abscesses are the most common deep space infection of the head and the neck with the incidence in pediatrics being approximately 14-20 cases per ...
  55. [55]
    Peritonsillar Abscess and Antibiotic Prescribing for Respiratory ...
    4. Reduction of antibiotic prescribing raises a concern that fewer antibi- ... Incidence of Peritonsillar Abscess. There were 9,870,559 registered patients ...<|separator|>
  56. [56]
    Full article: Post-Pandemic shifts in peritonsillar abscess: incidence ...
    The number of cases positive for Streptococcuspyogenes and Fusobacterium necrophorum increased post-NPI (n = 102 and n = 89, respectively) compared to during ...<|control11|><|separator|>
  57. [57]
    Seasonal variation and demographic characteristics of acute ...
    Oct 15, 2024 · Objective: Peritonsillar abscess (PTA) is a common soft tissue infection of the head and neck. It remains unclear to what extent inflammatory ...Missing: prevalence | Show results with:prevalence
  58. [58]
    Peritonsillar abscess: Incidence, current management practices, and ...
    rural difference in med- ical or surgical treatment for PTAs or in the number of. PTAs treated. The 1425 surveyed otolaryngologists, none of whom were retired, ...
  59. [59]
    Association between clinical outcome and microbiological findings ...
    May 14, 2025 · Peritonsillar abscesses can be caused by numerous pathogens, including Streptococcus pyogenes/Group A streptococci (GAS) as well as Group C/G ...
  60. [60]
    Initial Factors Influencing Duration of Hospital Stay in Adult Patients ...
    Jun 18, 2016 · The mean duration of hospitalization was 6.2±6.0 days. With univariate linear regression, a prolonged hospital stay was associated with several ...Missing: short- | Show results with:short-
  61. [61]
    An evidence-based review of peritonsillar abscess - PubMed
    Peritonsillar abscess is a common condition with increasing incidence. We demonstrate the potential for evidence-based modifications in clinical management.
  62. [62]
    The Impact of Prior Tonsillitis and Treatment Modality on the ... - NIH
    Oct 7, 2014 · The recurrence rate of PTA is poorly defined in the literature, ranging from 5% to 22%, with variability in age, sex, duration of follow-up, and ...
  63. [63]
    Outcomes of conservative antibiotic therapy in pediatric peritonsillar ...
    Sep 18, 2025 · Conclusions: Our findings suggest that conservative management of pediatric PTA with antibiotics is a safe and effective approach in selected ...
  64. [64]
    Peritonsillar abscess: recurrence rate and the indication ... - PubMed
    The patients were divided into those with a history of recurrent tonsillitis prior to developing PTA (72 patients, 25%), and those without (218 patients, 75%).
  65. [65]
    Inferior pole peritonsillar abscess - ScienceDirect.com
    One of the first references to the practice of incision and drainage of a peritonsillar abscess was by Hippocrates. The method of performing such drainage ...
  66. [66]
    The Historical Evolution of Oto-Laryngology - Sage Journals
    on "Diseases of the Nose and Throat "! Celsus has much to say in regard to cynanche (quinsy), as indeed had all the ancient authors, and he describes the ...
  67. [67]
    Giovanni Battista Morgagni and his contribution to pediatric surgery
    He was also the first to describe pediatric pathological conditions like epispadia, meconium peritonitis, Crohn's disease, and coarctation of the aorta. Finally ...Missing: peritonsillar abscess
  68. [68]
    The Discovery of Penicillin—New Insights After More Than 75 Years ...
    After just over 75 years of clinical use, it is clear that penicillin's initial impact was immediate and profound.
  69. [69]
    Respiratory Infections in the U.S. Military: Recent Experience and ...
    Group A streptococcus respiratory infections have had a long history of impact on the U.S. military dating back to WWII, where such infections associated with ...
  70. [70]
    [PDF] SAS Journal of Medicine (SASJM) Perıtonsıllar Abscess
    Needle aspiration and drainage became popular in the United States in the 1980s [15]. In a large number of studies, peritonsillar abscess treatment, needle.
  71. [71]
    CT-guided transcutaneous drainage of peritonsillar abscess after ...
    Nov 25, 2023 · This case exhibits an uncommon approach to PTA aspiration via an external CT-guided percutaneous approach with rapid subsequent clinical improvement.
  72. [72]
    Tonsil - Etymology, Origin & Meaning
    Originating c. 1600 from Latin "tonsillae," diminutive of "toles" meaning "goiter," tonsil refers to lymphatic tissue in the throat, linked to immune ...
  73. [73]
    Abscess - Etymology, Origin & Meaning
    Abscess, from Latin abscessus (1610s), means a pus collection in the body; origin traces to abscedere, "to withdraw," reflecting humors leaving via pus.
  74. [74]
    QUINSY Definition & Meaning - Merriam-Webster
    Middle English quinesie, from Anglo-French esquinauncy, quinancie, from Late Latin cynanche, from Greek kynanchē, from kyn-, kyōn dog + anchein to strangle ...
  75. [75]
    quinsy - Wiktionary, the free dictionary
    From Middle English quinesye, from Old French quinencie, from Medieval Latin quinancia, from Ancient Greek κυνάγχη (kunánkhē, “canine quinsy”), from κύων (kúōn, ...
  76. [76]
    peritonsillar, adj. meanings, etymology and more | Oxford English ...
    Where does the adjective peritonsillar come from? ... The earliest known use of the adjective peritonsillar is in the 1870s. OED's earliest evidence for ...
  77. [77]
    peritonsillar abscess - Translation into French - examples English
    Peritonsillar abscess and cellulitis are acute pharyngeal infections most common among adolescents and young adults. L'abcès périamygdalien et la cellulite sont ...